about
Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population.Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis.Circulating soluble interleukin-2 receptor level predicts remission in very early reactive arthritis.Cellular and humoral markers of systemic inflammation in acute reactive arthritis and early rheumatoid arthritis.Impact of rheumatic diseases on oral health and quality of life.Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal statusA6.02 Somatic mutations in clonally expanded CD8+T cells in patients with newly diagnosed rheumatoid arthritisActivity of rheumatoid arthritis correlates with oral inflammatory burden
P50
Q35636544-87930E0C-81AB-418B-A886-1FB4951CB658Q37627252-AA652DA9-3DD1-4FE4-B5F4-317B7401C0B2Q40815075-315A47E2-EFE2-4A53-B1DA-708200CC8C66Q44782211-A699DB40-A375-45A2-BF3C-2C556EAAF7BCQ47655049-3FF97BA1-1363-4E5B-BB64-0DCE5562A258Q48067085-509A9A57-E3E8-4666-891C-A829886F5542Q58136286-200D3FCE-F679-4C75-884C-04F26BC0E7A4Q61776671-4930F6FB-C5B6-413C-A828-0F4313506ABDQ90457501-4EF21D3F-9552-4241-AC57-82C73AAB2ED3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antti Kuuliala
@ast
Antti Kuuliala
@en
Antti Kuuliala
@es
Antti Kuuliala
@nl
type
label
Antti Kuuliala
@ast
Antti Kuuliala
@en
Antti Kuuliala
@es
Antti Kuuliala
@nl
prefLabel
Antti Kuuliala
@ast
Antti Kuuliala
@en
Antti Kuuliala
@es
Antti Kuuliala
@nl
P106
P31
P496
0000-0002-3190-207X